{
  "compound": "Various cannabinoids in animal models",
  "condition": "PARKINSONS",
  "effect_size": "N/A (preclinical review)",
  "study_type": "PRECLINICAL_REVIEW",
  "source": "NORML:PD_PRECLINICAL_001",
  "participants": "Review of preclinical studies",
  "year": 2016,
  "notes": "Cannabinoid Neuroprotection in Parkinson's Disease Models: Comprehensive Review",
  "confidence": "medium",
  "abstract": "THC: Dopaminergic neuron protection in 6-OHDA and MPTP models; CBD: Anti-inflammatory, antioxidant; THCV: CB2 receptor-mediated protection"
}